Umbilical Cord Blood Banking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The global umbilical cord blood (UCB) banking market has experienced a meteoric rise in recent years, driven by a convergence of factors including the increasing prevalence of chronic diseases and advancements in regenerative medicine. Recent market analyses indicate that this growth trajectory is poised to continue, with significant milestones projected by the year 2031.

Market Overview

Umbilical cord blood, sourced from newborns' umbilical cords and placentas, harbors valuable adult stem cells crucial for various biological processes and tissue development in humans. The UCB banking market has witnessed substantial growth, with a compound annual growth rate (CAGR) reflecting its expanding importance in healthcare.

Market Drivers

The growth of the global UCB banking market is fueled by the rising incidence of chronic diseases and the burgeoning field of regenerative medicine. Government associations and initiatives worldwide have played a pivotal role in supporting this growth trajectory. Notably, North America leads the market, followed by Europe and the Asia-Pacific region.

Market Restraints

Despite its promising outlook, the UCB banking market faces challenges such as stringent licensing and accreditation procedures. Additionally, the high costs associated with private UCB banks pose a barrier to market expansion. However, emerging trends like allogeneic hematopoietic stem cell transplantation and cord tissue storage are reshaping the market landscape.

Geographical Insights: Driving Forces of UCB Banking Market Growth

North America

North America serves as the cornerstone of the UCB banking market, with the United States and Canada playing pivotal roles. The region's dominance is fueled by a multifaceted approach, combining the rising prevalence of chronic diseases with proactive government initiatives aimed at fostering awareness around cord blood donation. As chronic diseases continue to pose significant healthcare challenges, the emphasis on UCB banking as a potential therapeutic solution has intensified.

Europe

In Europe, a growing recognition of cord blood's therapeutic potential has spurred market expansion. The continent's landscape is evolving, marked by a growing awareness among healthcare professionals and the general public regarding the diverse applications of cord blood. Additionally, the steady increase in live births across European nations has contributed to the momentum, providing a steady stream of potential donors. Initiatives aimed at encouraging families to donate and preserve cord blood have gained considerable traction, underscoring Europe's position as a significant player in the global UCB banking market.

Asia-Pacific

The Asia-Pacific region emerges as a dynamic hub of UCB banking market growth, driven by escalating rates of chronic diseases and a growing awareness of cord blood's therapeutic applications. With populous nations such as China and India boasting the highest number of live births globally, the region is poised for substantial market expansion. As healthcare infrastructure continues to evolve and awareness campaigns gain momentum, the uptake of UCB banking services is expected to surge. Moreover, the region's diverse demographic landscape presents fertile ground for market penetration and innovation, further catalyzing its emergence as the fastest-growing market segment in the global UCB banking arena.

Key Market Players Include

Cord Blood Registry Systems, Inc.
Cordlife Group Limited.
Cord Blood America, Inc.
NeoStem Inc.
Cryo-Cell International, Inc.
ViaCord.
Esperite NV.
Smart Cells International Ltd.
China Cord Blood Corporation.
Other

Global Umbilical Cord Blood Banking market is Segmented as Below:

By Therapeutic Application of UCB:

Leukemia
Bone Marrow Failure Syndrome
Metabolic/Storage Diseases
Lymphoma
Immune Deficiencies

By Storage Option:

Private UCB Banks
Public UCB Banks

By Region:

North America

Latin America

Europe

South Asia & Oceania

East Asia

Middle East & Africa (MEA)

1. Executive Summary

1.1. Global Umbilical Cord Blood Banking Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Umbilical Cord Blood Banking Market Outlook, 2018 - 2031

3.1. Global Umbilical Cord Blood Banking Market Outlook, By Therapeutic Application, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Leukemia
  - 3.1.1.2. Bone Marrow Failure Syndrome
  - 3.1.1.3. Metabolic/Storage Diseases
  - 3.1.1.4. Lymphoma
  - 3.1.1.5. Immune Deficiencies
3.2. Global Umbilical Cord Blood Banking Market Outlook, By Storage Option, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Private UCB Banks
  - 3.2.1.2. Public UCB Banks
3.3. Global Umbilical Cord Blood Banking Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Umbilical Cord Blood Banking Market Outlook, 2018 - 2031

4.1. North America Umbilical Cord Blood Banking Market Outlook, By Therapeutic Application, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Leukemia
  - 4.1.1.2. Bone Marrow Failure Syndrome
  - 4.1.1.3. Metabolic/Storage Diseases
  - 4.1.1.4. Lymphoma
  - 4.1.1.5. Immune Deficiencies
4.2. North America Umbilical Cord Blood Banking Market Outlook, By Storage Option, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Private UCB Banks
  - 4.2.1.2. Public UCB Banks
4.3. North America Umbilical Cord Blood Banking Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Umbilical Cord Blood Banking Market Outlook, 2018 - 2031

5.1. Europe Umbilical Cord Blood Banking Market Outlook, By Therapeutic Application, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Leukemia
  - 5.1.1.2. Bone Marrow Failure Syndrome
  - 5.1.1.3. Metabolic/Storage Diseases
  - 5.1.1.4. Lymphoma
  - 5.1.1.5. Immune Deficiencies
5.2. Europe Umbilical Cord Blood Banking Market Outlook, By Storage Option, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Private UCB Banks
  - 5.2.1.2. Public UCB Banks
5.3. Europe Umbilical Cord Blood Banking Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkiye Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkiye Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Umbilical Cord Blood Banking Market Outlook, 2018 - 2031

6.1. Asia Pacific Umbilical Cord Blood Banking Market Outlook, By Therapeutic Application, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Leukemia
  - 6.1.1.2. Bone Marrow Failure Syndrome
  - 6.1.1.3. Metabolic/Storage Diseases
  - 6.1.1.4. Lymphoma
  - 6.1.1.5. Immune Deficiencies
6.2. Asia Pacific Umbilical Cord Blood Banking Market Outlook, By Storage Option, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Private UCB Banks
  - 6.2.1.2. Public UCB Banks
6.3. Asia Pacific Umbilical Cord Blood Banking Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Umbilical Cord Blood Banking Market Outlook, 2018 - 2031

7.1. Latin America Umbilical Cord Blood Banking Market Outlook, By Therapeutic Application, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Leukemia
  - 7.1.1.2. Bone Marrow Failure Syndrome
  - 7.1.1.3. Metabolic/Storage Diseases
  - 7.1.1.4. Lymphoma
  - 7.1.1.5. Immune Deficiencies
7.2. Latin America Umbilical Cord Blood Banking Market Outlook, By Storage Option, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Private UCB Banks
  - 7.2.1.2. Public UCB Banks
7.3. Latin America Umbilical Cord Blood Banking Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Umbilical Cord Blood Banking Market Outlook, 2018 - 2031

8.1. Middle East & Africa Umbilical Cord Blood Banking Market Outlook, By Therapeutic Application, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Leukemia
  - 8.1.1.2. Bone Marrow Failure Syndrome
  - 8.1.1.3. Metabolic/Storage Diseases
  - 8.1.1.4. Lymphoma
  - 8.1.1.5. Immune Deficiencies
8.2. Middle East & Africa Umbilical Cord Blood Banking Market Outlook, By Storage Option, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Private UCB Banks
  - 8.2.1.2. Public UCB Banks
8.3. Middle East & Africa Umbilical Cord Blood Banking Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Rest of Middle East & Africa Umbilical Cord Blood Banking Market By Therapeutic Application, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Umbilical Cord Blood Banking Market By Storage Option, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Company Market Share Analysis, 2022
9.2. Competitive Dashboard
9.3. Company Profiles
- 9.3.1. Cord Blood Registry Systems, Inc.
  - 9.3.1.1. Company Overview
  - 9.3.1.2. Product Portfolio
  - 9.3.1.3. Financial Overview
  - 9.3.1.4. Business Strategies and Development
- 9.3.2. Cordlife Group Limted
  - 9.3.2.1. Company Overview
  - 9.3.2.2. Product Portfolio
  - 9.3.2.3. Financial Overview
  - 9.3.2.4. Business Strategies and Development
- 9.3.3. Cord Blood America, Inc.
  - 9.3.3.1. Company Overview
  - 9.3.3.2. Product Portfolio
  - 9.3.3.3. Financial Overview
  - 9.3.3.4. Business Strategies and Development
- 9.3.4. NeoStem, Inc.
  - 9.3.4.1. Company Overview
  - 9.3.4.2. Product Portfolio
  - 9.3.4.3. Financial Overview
  - 9.3.4.4. Business Strategies and Development
- 9.3.5. Cryo-Cell International, Inc.
  - 9.3.5.1. Company Overview
  - 9.3.5.2. Product Portfolio
  - 9.3.5.3. Financial Overview
  - 9.3.5.4. Business Strategies and Development
- 9.3.6. ViaCord
  - 9.3.6.1. Company Overview
  - 9.3.6.2. Product Portfolio
  - 9.3.6.3. Financial Overview
  - 9.3.6.4. Business Strategies and Development
- 9.3.7. Esperite N.V.
  - 9.3.7.1. Company Overview
  - 9.3.7.2. Product Portfolio
  - 9.3.7.3. Financial Overview
  - 9.3.7.4. Business Strategies and Development
- 9.3.8. StemCyte
  - 9.3.8.1. Company Overview
  - 9.3.8.2. Product Portfolio
  - 9.3.8.3. Financial Overview
  - 9.3.8.4. Business Strategies and Development
- 9.3.9. Smart Cells International, Ltd.
  - 9.3.9.1. Company Overview
  - 9.3.9.2. Product Portfolio
  - 9.3.9.3. Financial Overview
  - 9.3.9.4. Business Strategies and Development
- 9.3.10. China Cord Blood Corporation
  - 9.3.10.1. Company Overview
  - 9.3.10.2. Product Portfolio
  - 9.3.10.3. Financial Overview
  - 9.3.10.4. Business Strategies and Development

10. Appendix

10.1.Research Methodology
10.2.Report Assumptions
10.3.Acronyms and Abbreviations